Research indicates that mutations in the Keap1/Nrf2 pathway or imbalanced regulation of this system contribute to the development of tumors in people and facilitate the advancement of cancer by continuously activating Nrf2 and altering cell metabolism (83). Here, KEAP1 is linked to cancer.